ACUTE LYMPHOBLASTIC LEUKEMIA THERAPEUTICS MARKET ANALYSIS

Acute Lymphoblastic Leukemia Therapeutics MarketSize and Trends

Market Dynamics

Increasing incidence of acute lymphoblastic leukemia coupled with rising association of the disease with genetic disorders such as Down syndrome in children is a major factor augmenting the market growth. According to the Healthline Media UK Ltd., 2017, ALL accounts for 80% of childhood leukemia and is the most common type of cancer and leukemia in children under 5 years of age than in adults, mostly affecting children aged 2 to 3 years. Also, according to survey by MedicineNet, a medical information portral, about two-thirds of acute leukemia diagnosed in children are associated with Down syndrome, thus increasing the likelihood of children affected with genetic disorders to develop ALL. Furthermore, factors such as high exposure to toxins- benzene and radiations such as X-rays before birth are expected to increase risk of developing ALL and this is expected to propel demand for treatment of the disease using various therapeutics. Therefore, this is expected to aid in growth of the market.

Furthermore, increasing approval of novel treatments such as immune cell gene therapy to treat the condition is also expected to aid in growth of the global acute lymphoblastic lymphoma market. For instance, in August 2017, the U.S. Food and Drug Administration approved chimeric antigen receptor T cell (CAR-T) therapy, Kymriah (tisagenlecleucel) manufactured by Novartis Pharmaceuticals Corporation. The therapy is indicated for patients up to 25 years of age with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

Also, various private and public organizations are engaged in extensive research to develop novel therapeutics, which in turn is expected to bolster the market growth during the forecast period. For instance, the Leukemia and Lymphoma Society (LLS) has funded over US $ 1.2 Billion in cutting-edge research to develop cure for blood cancer. LLS is also focused on improving the lives of patients by providing free information and support services.

Market- Trends